Stocks and Investing Stocks and Investing
Wed, September 20, 2023

Gil Blum Reiterated (TSHA) at Strong Buy and Held Target at $5 on, Sep 20th, 2023


Published on 2024-10-28 06:29:32 - WOPRAI, Gil Blum
  Print publication without navigation


Gil Blum of Needham, Reiterated "Taysha Gene Therapies, Inc." (TSHA) at Strong Buy and Held Target at $5 on, Sep 20th, 2023.

Gil has made no other calls on TSHA in the last 4 months.



There are 4 other peers that have a rating on TSHA. Out of the 4 peers that are also analyzing TSHA, 0 agree with Gil's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Gil


  • Geulah Livshits of "Chardan Capital" Reiterated at Strong Buy and Held Target at $5 on, Tuesday, August 15th, 2023
  • Jack Allen of "Baird" Maintained at Buy with Increased Target to $8 on, Tuesday, August 15th, 2023
  • Silvan Tuerkcan of "JMP Securities" Reiterated at Buy and Held Target at $4 on, Tuesday, August 15th, 2023
  • Kristen Kluska of "Cantor Fitzgerald" Maintained at Buy with Increased Target to $7 on, Monday, August 14th, 2023
Contributing Sources